Quick Answer
Onconetix, Inc. reported Net Income of -$14.03 million for fiscal year 2025.
Onconetix, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$14.03M | +76.1% |
| 2024 | -$58.69M | -56.9% |
| 2023 | -$37.41M | -178.8% |
| 2022 | -$13.42M | -292.7% |
| 2021 | -$3.42M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.78M | -129.5% | -270.2% |
| June 30, 2025 | -$2.37M | +83.4% | +72.2% |
| March 31, 2025 | -$8.55M | +23.1% | -123.3% |
| September 30, 2024 | -$3.83M | +28.4% | +73.2% |
| June 30, 2024 | -$14.31M | -108.4% | -28.7% |
| March 31, 2024 | -$11.12M | -290.6% | -107.9% |
| September 30, 2023 | -$5.35M | -38.3% | +22.1% |
| June 30, 2023 | -$6.87M | -61.0% | -141.2% |
- Onconetix, Inc. showed an increase of +76.1% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, Onconetix, Inc.’s net income has declined by 310.6% (from -$3.42 million to -$14.03 million).
- The most recent figure is from Onconetix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: